Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hepatoblastoma × Cyclophosphamide × Clear all

Sponsor

Conditions

Breast Neoplasms 138 Lymphoma 137 Precursor Cell Lymphoblastic Leukemia-Lymphoma 113 Lymphoma, Non-Hodgkin 107 Leukemia 106 Leukemia, Lymphocytic, Chronic, B-Cell 102 Multiple Myeloma 100 Lymphoma, Large B-Cell, Diffuse 86 Leukemia, Myeloid, Acute 83 Hodgkin Disease 72 Myelodysplastic Syndromes 70 Lymphoma, Follicular 67 Lymphoma, Mantle-Cell 66 Burkitt Lymphoma 59 Lymphoma, B-Cell, Marginal Zone 47 Melanoma 44 Neoplasms 40 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39 Recurrence 32 Lymphoma, Large-Cell, Immunoblastic 31 Hematologic Neoplasms 31 Neoplasms, Plasma Cell 28 Leukemia, Myelomonocytic, Chronic 27 Myeloproliferative Disorders 26 Primary Myelofibrosis 24 Lymphoma, Large-Cell, Anaplastic 24 Lymphoma, B-Cell 24 Congenital Abnormalities 24 Leukemia, Myeloid, Chronic-Phase 23 Leukemia, Myeloid, Accelerated Phase 23

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Biopsy 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 erdafitinib 1 cixutumumab 1 Vemurafenib 1 Pharmacogenomic Variants 1 MLN 8237 1 LY3023414 1 Cyproheptadine 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡